Brent Sabatini, SVP, Chief Accounting Officer at Vir Biotechnology, Inc. (VIR), sold 1,829 shares at $7.45 ($14K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Scheduled sale ($14k) by SVP, Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2026-02-26 | $14K | — | Filing → |
| VIR | SELL | 2026-02-18 | $12K | — | Filing → |
| VIR | SELL | 2025-02-25 | $15K | — | Filing → |